CGP Insight | Will loose epidemic prevention policies affect the bio-pharmaceutical industry?
At the end of 2022, according to the latest regulations on optimizing the implementation of epidemic prevention and control measures issued by the National Health Commission. the barriers to transfer by cross- provinces reduced. We felt that we were gradually recovering normally ; How will this situation affect the biomedical talent market?